PMS2 and colorectal carcinoma: For CRC ISMCs, to the extent that they tend to be right-sided, mucinous, lymphoplasmacytic, MLH1/PMS2 deficient with BRAF mutations, they seem to be aligned with the hypermutated molecular phenotype [36–38].